[Value of hydralazine-beta blockader association in hypertension of pregnancy].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D010096:Oxprenolol / Q000008:administration & dosage / Q000627:therapeutic use; D010869:Pindolol / Q000008:administration & dosage / Q000627:therapeutic use; D011225:Pre-Eclampsia / Q000188:drug therapy; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D006830:Hydralazine; D010096:Oxprenolol; D011433:Propranolol; D010869:Pindolol
L'intérêt de l'association dihydralazine-beta-bloquants dans les hypertensions de la grossesse.